PRECLINICAL TESTING OF THE EFFICACY AND SAFETY OF CRISPR/CAS9 GENE EDITED CAR-T CELL THERAPY FOR DIFFUSE MIDLINE GLIOMA (DMG)

被引：0

作者：

Balakrishnan, Ilango ^{[1
]}

Leach, Lillie ^{[1
]}

Pierce, Angela ^{[1
]}

Lakshmanachetty, Senthilnath ^{[1
]}

Madhavan, Krishna ^{[1
]}

Fosmire, Susan ^{[1
]}

Chatwin, Hannah ^{[1
]}

Green, Adam ^{[1
]}

Fry, Terry ^{[1
]}

Vibhakar, Rajeev ^{[1
]}

Kohler, Eric. M. ^{[1
]}

Venkataraman, Sujatha ^{[1
]}

机构：

[1] Univ Colorado, Aurora, CO USA

来源：

NEURO-ONCOLOGY | 2023年 / 25卷

关键词：

D O I：

10.1093/neuonc/noad073.079

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

DIPG-32

引用

页数：1

共 50 条

[31] CRISPR/Cas9 and CAR-T cell, collaboration of two revolutionary technologies in cancer immunotherapy, an instruction for successful cancer treatment
Mollanoori, Hasan
Shahraki, Hojat
Rahmati, Yazdan
Teimourian, Shahram
HUMAN IMMUNOLOGY, 2018, 79 (12) : 876 - 882
[32] Allogeneic CAR-T cell products containing 10 gene edits using CRISPR/Cas9 can retain full functionality in vivo and in vitro
McEwan, Brigid
Kuppuraju, Meghna
Padalia, Zinkal
Terrett, Jonathan
Kalaitzidis, Demetrios
CANCER RESEARCH, 2020, 80 (16)
[33] Generating primary mouse models of diffuse midline glioma through a combination of the RCAS/tv- a retrovirus system and CRISPR/Cas9 gene editing
Wu, Sophie R.
Liu, Harrison Q.
Tolliver, Joshua
Maingi, Spencer M.
Valentine, Vennesa
Williams, Nerissa T.
Reitman, Zachary J.
CANCER RESEARCH, 2024, 84 (06)
[34] How CRISPR/Cas9 Gene Editing Is Revolutionizing T Cell Research
Johansen, Kristoffer Haurum
DNA AND CELL BIOLOGY, 2022, 41 (01) : 53 - 57
[35] Emerging CRISPR/Cas9 applications for T-cell gene editing
Preece, Roland
Georgiadis, Christos
EMERGING TOPICS IN LIFE SCIENCES, 2019, 3 (03) : 261 - 275
[36] Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9
Ren, Jiangtao
Zhao, Yangbing
PROTEIN & CELL, 2017, 8 (09) : 634 - 643
[37] Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9
Jiangtao Ren
Yangbing Zhao
Protein & Cell, 2017, 8 (09) : 634 - 643
[38] Universal allogeneic CAR-T cells engineered with Sleeping Beauty transposons and CRISPR/Cas9 for cancer immunotherapy
Tipanee, J.
Samara-Kuko, E.
Gevaert, T.
Chuah, M. K.
VandenDriessche, T.
HUMAN GENE THERAPY, 2022, 33 (23-24) : A124 - A124
[39] Novel technologies for improving the safety and efficacy of CAR-T cell therapy
Keisuke Ohta
Yukimi Sakoda
Koji Tamada
International Journal of Hematology, 2023, 117 : 647 - 651
[40] Editorial: Efficacy and safety of CAR-T cell therapy in hematologic malignancies
de Lima, Marcos
Di Rocco, Alice
Ribera, Jose-Maria
FRONTIERS IN ONCOLOGY, 2024, 14

← 1 2 3 4 5 →